The Antiapoptotic Function of miR-96 in Prostate Cancer by Inhibition of FOXO1

FOXO1 is a tumor suppressor in classical Hodgkin lymphoma

(2012) L. Xie et al.   BLOOD

miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate Cells

(2011) Brittany L. Mihelich et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Distinctive microRNA signature of medulloblastomas associated with the WNT signaling pathway

(2011) NeelamVishwanath Shirsat et al.   Journal of Cancer Research and Therapeutics

Molecular basis of differential target regulation by miR-96 and miR-182: the Glypican-3 as a model

(2011) Sandra Jalvy-Delvaille et al.   NUCLEIC ACIDS RESEARCH

MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria

(2011) Fumiaki Sato et al.   PLoS One

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

miRNA-96 Suppresses KRAS and Functions as a Tumor Suppressor Gene in Pancreatic Cancer

(2010) S. Yu et al.   CANCER RESEARCH

Camptothecin Induces Apoptosis of Human Retinoblastoma Cells via Activation of FOXO1

(2010) Song Han et al.   CURRENT EYE RESEARCH

KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy

(2010) Anja Rabien et al.   INTERNATIONAL JOURNAL OF CANCER

Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a

(2010) Huanxin Lin et al.   PLoS One

MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells

(2009) Tao Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states

(2009) Aaron L Sarver et al.   BMC CANCER

PAX3–FKHR sensitizes human alveolar rhabdomyosarcoma cells to camptothecin-mediated growth inhibition and apoptosis

(2009) Fu-Yue Zeng et al.   CANCER LETTERS

Definition of microRNAs That Repress Expression of the Tumor Suppressor Gene FOXO1 in Endometrial Cancer

(2009) S. S. Myatt et al.   CANCER RESEARCH

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

(2009) Todd Morgan et al.   CURRENT CANCER DRUG TARGETS

Expression patterns of miR-96, miR-182 and miR-183 in the developing inner ear

(2009) Rosalie Sacheli et al.   GENE EXPRESSION PATTERNS

Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells

(2009) Irene K. Guttilla et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MUC1 Expression in Incidental Prostate Cancer Predicts Staging and Grading on the Subsequent Radical Prostatectomy

(2009) Sven Gunia et al.   PATHOLOGY & ONCOLOGY RESEARCH

Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types

(2009) Roy Navon et al.   PLoS One

Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

(2008) S. Ambs et al.   CANCER RESEARCH

Widespread changes in protein synthesis induced by microRNAs

(2008) Matthias Selbach et al.   NATURE

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

(2008) Witold Filipowicz et al.   NATURE REVIEWS GENETICS

CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor

(2008) P Liu et al.   ONCOGENE

Loss of mir-146a function in hormone-refractory prostate cancer

(2008) S.-L. Lin et al.   RNA